Rakesh Jain, MD, MPH, RD

The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder

Introduction: Depressive episodes/symptoms of bipolar I disorder (BPD-I) are commonly misdiagnosed as major depressive disorder (MDD). We developed the novel and pragmatic Rapid Mood Scre...

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;

Kate Sullivan , APN, RN;

Lauren Nelson , PhD;

Roger McIntyre , MD, FRCPC;

Susan McElroy , MD;

Rakesh Jain , MD, MPH, RD;

Charles Brendan Montano , MD;

Mehul Patel , MD, PharmD;

T. Michelle Brown , PhD;

Prakash M. Masand , MD;

10/08/2020

Videos

Approaching Psychedelics for Depression With Both Caution and Optimism

02/06/2024

Rakesh Jain , MD, MPH, RD;

Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.

Rakesh Jain, MD, MPH, explains...

02/06/2024

Psych Congress Network

Impact of Lemborexant on Patient-Reported Insomnia-Related Worry/Distress and Interference With Daily Functioning Over 6 Months: Results From SUNRISE-2

INTRODUCTION: The insomnia severity index (ISI) is a self-report instrument that evaluates perception of insomnia severity. In Study 303 (SUNRISE-2), lemborexant (LEM) showed greater red...

Rakesh Jain , MD, MPH, RD;

Jane Yardley , PhD;

Kate Pinner , MSc;

Manoj Malhotra , MD;

Margaret Moline , PhD;

Norman Atkins Jr., MBA, PhD;

Craig Chepke , MD, DFAPA;

10/08/2020

Effect of Lemborexant Treatment Across 12 Months on Fatigue Severity and Sleep Outcomes in Subjects With Clinically Significant Fatigue at Baseline

Introduction: The Fatigue Severity Scale (FSS) assesses impact of fatigue on patients’ lives. Lemborexant (LEM) efficacy was examined in the subgroup of subjects with baseline FSS total s...

Norman Atkins Jr., MBA, PhD;

Craig Chepke , MD, DFAPA;

Rakesh Jain , MD, MPH, RD;

Jane Yardley , PhD;

Manoj Malhotra , MD;

Kate Pinner , MSc;

Margaret Moline , PhD;

10/08/2020

Quiz

What is the most exciting neurotransmitter in depression treatment?

10/07/2024

Rakesh Jain , MD, MPH, RD;

Brooke Kempf , MSN, PMHNP-BC;

Test your knowledge with a quick quiz!

Test your knowledge with a quick...

10/07/2024

Psych Congress NP Institute

Clinical Pearls

Targeting Non-Monoaminergic Pathways in MDD and TRD Treatment

09/30/2024

Rakesh Jain , MD, MPH, RD;

Brooke Kempf , MSN, PMHNP-BC;

Learn how this critical neurotransmitter is reshaping our understanding of depression, cognition, and mood disorders.

Learn how this critical...

09/30/2024

Psych Congress NP Institute

Clinical Pearls

Unmet Needs and Limitations in TRD and MDD Treatment

09/26/2024

Rakesh Jain , MD, MPH, RD;

Brooke Kempf , MSN, PMHNP-BC;

Explore the current challenges in treating MDD in a discussion with Brooke Kempf, MSN, PMHNP-BC, and Rakesh Jain, MD, MPH.

Explore the current challenges...

09/26/2024

Psych Congress NP Institute

Clinical Pearls

Key Challenges in Accurately Diagnosing Bipolar Disorder

09/25/2024

Rakesh Jain , MD, MPH, RD;

  In this video from on-site at NP Institute 2024 in Boston, Massachusetts, Rakesh Jain, MD, MPH, psychiatrist at Mental Wellness in Austin, Texas, tackles the complex challenge of diagnosing and differentiating bipolar...

  In this video...

09/25/2024

Psych Congress NP Institute